Aiforia and Orion collaborate to develop AI solutions for image analytics in drug research
Aiforia and Finnish pharmaceutical company Orion have agreed to collaborate on developing AI-based image analysis solutions for preclinical research and product development.
Aiforia Technologies Plc, Press Release, 05 July 2023 at 12:00 a.m. EEST Aiforia and Finnish pharmaceutical company Orion have agreed to collaborate on developing AI-based image analysis solutions for preclinical research and product development. Through this collaboration, Aiforia will gain valuable insight from Orion into the needs of its preclinical customer base and will be better able to address these needs with its product portfolio.
In spring 2023, Orion launched a Business Finland-funded project that aims to shorten the development time of new innovative medicines by using data and artificial intelligence. The partnership with Orion supports Aiforia’s strategy to rapidly bring internationally unique AI solutions to the market that can enhance both preclinical research and clinical diagnostics.
Further enquiries
Jukka Tapaninen, CEO, Aiforia Technologies Plc, tel. +33 61 041 6686 www.investors.aiforia.com
Certified Adviser
UB Securities Ltd, tel. +358 9 25 380 225
About Aiforia
Aiforia equips pathologists and scientists in preclinical and clinical labs with powerful deep-learning artificial intelligence software for translating images into discoveries, decisions, and diagnoses. The cloud-based Aiforia products and services aim to escalate the efficiency and precision of medical image analysis beyond current capabilities across various fields, from oncology to neuroscience and more. Find out more: www.aiforia.com.
SOURCE: Aiforia
